Litfulo (ritlecitinib) [prescribing information]. New York, NY: Pfizer; June 2024. Policy Revision history. Rev Type of Change. Summary of
Prescribing information. Nutley, NJ: Eisai. Inc.; January 2024. Zavzpret. Prescribing information. New York, NY: Pfizer Labs; March 2024. Litfulo.
REQUIRED MEDICAL INFORMATION: This clinical policy is consistent Litfulo (ritlecitinib) [prescribing information]. New York, NY
Please see full Prescribing Information, including BOXED WARNING, and Medication Guide for LITFULO, and full Prescribing Information, including BOXED
complete, correct, or legible, the authorization process can be delayed. Drug Requested: Litfulo (ritlecitinib). MEMBER PRESCRIBER INFORMATION: Authorization
Litfulo (ritlecitinib) [prescribing information]. 2024. Accessed
Litfulo (Ritlecitinib) 2 Additional requirements listed in the Indications and Usage sections of the prescribing information
Please see the prescribing guidelines for further information Consider cost. Ritlecitinib (Litfulo ) View adult BNF View SPC online View childrens BNF
What are the possible side effects of LITFULO? LITFULO may cause serious side effects, including: See What is the most important information I should know about LITFULO? The most common side effects of LITFULO include: headache diarrhea acne rash hives inflamed hair pores (folliculitis) fever eczema
Comments
SHOULD BE:
Andy had literally simply RELAYED all the various information.